Last year we did a survey of our medical professional readers from across the country to gauge the level of knowledge you had on GLP-1 analogs. We focused on the science, research and benefits of this new class of drugs.
Based on your responses we have spent the last year providing a well-received series of special editions. This month we have taken the best of these editions, added new data as well as a great slide presentation from our UF College of Pharmacy Intern, Alan Mathis, on the cardiovascular benefits of the class, to give you an information-packed edition.
Be sure to check out last year’s survey questions and see if you can answer them all correctly this year.